Matthew Gagne

12PUBLICATIONS
151CO-AUTHORS
Innate immunityNanomedicineGene and molecular therapyMedical infection agents (incl. prions)Te mātauranga Māori i roto i te mātauranga (Mātauranga Māori in education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.

Chieh-Yu Liang, Saravanan Raju, Zhuoming Liu

|Jan 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2.

Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren

|Jul 28, 2023
Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques.

Elise G Viox, Timothy N Hoang, Amit A Upadhyay

|Jul 28, 2023
RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.

Matthew Gagne, Barbara J Flynn, Christopher Cole Honeycutt

|Mar 17, 2023
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.

Ohad Yogev, Omer Weissbrod, Giorgia Battistoni

|Oct 23, 2022
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine.

Dapeng Li, David R Martinez, Alexandra Schäfer

Pageof 2